《生命科学》 2010, 22(11): 1192-1195
摘 要:摘 要:白细胞介素-6是多发性骨髓瘤(multiple myeloma,MM)瘤细胞生长和生存的关键因子,也是MM患者发病的主要因子。IL-6/IL-6R系统通过不同通路影响多发性骨髓瘤瘤细胞生长并导致患者骨损害、类风湿性关节炎等一系列并发症。针对IL-6/IL-6R系统的治疗方法将给MM的治疗带来重大的进展。
关键词:IL-6/IL-6R;gp130;多发性骨髓瘤
Abstract: Abstract: Interleukin-6 is a key growth and survival factor, which is involved in tumorigenesis of multiple myeloma. The proliferation of malignant cells in multiple myeloma are affected through different pathways of IL-6/IL-6R ,which also could lead to bone damage, rheumatoid arthritis and some other complications in patients. Treatment of MM targeted IL-6/IL-6R system will provide a new therapeutic approach based on interruption of IL-6 mediated tumor cell growth in future.
Key words: IL-6/IL-6R; gp130; multiple myeloma